Analgesic activity and pharmacological characterization of N-[1-phenylpyrazol-3-yl]-N-[1-(2-phenethyl)-4-piperidyl] propenamide, a new opioid agonist acting peripherally

European Journal of Pharmacology
Carlos GoicoecheaMaria Isabel Martín

Abstract

We previously reported the synthesis of three new opioid agonists as well as their in vitro and in vivo activity [Girón, R., Abalo, R., Goicoechea, C., Martín, M.I., Callado, L.F., Cano, C., Goya, P., Jagerovic, N. 2002. Synthesis and opioid activity of new fentanyl analogs. Life Sci. 71, 1023-1034]. One of them, N-[1-phenylpyrazol-3-yl]-N-[1-(2-phenethyl)-4-piperidyl)] propenamide (IQMF-4), showed an interesting antinociceptive activity. Intraperitoneally (i.p.) administered, it was as effective as fentanyl or morphine, being less potent than fentanyl but more so than morphine. The aim of the present work was to evaluate its antinociceptive effect by different routes of administration, using the hot plate test, and to investigate possible side effects, such as tolerance and withdrawal, in vitro, using the myenteric plexus-longitudinal muscle strip preparation from guinea pig ileum, and in vivo, using the hot plate test. IQMF-4 was more potent than morphine when administered per os (p.o.), but less potent when administered intracerebroventricularly (i.c.v.). By both routes, fentanyl is more potent that IQMF-4. When IQMF-4 was administered i.p., naloxone methiodide, a peripherally acting antagonist, was able to completely block ...Continue Reading

References

Jan 1, 1985·Advances in Alcohol & Substance Abuse·J P Morgan
Mar 28, 1996·European Journal of Pharmacology·I LizasoainP Lorenzo
Feb 2, 1999·Acta Anaesthesiologica Scandinavica·G VarrassiA Ciccone
Jun 29, 2002·Life Sciences·Rocío GirónNadine Jagerovic
Jun 29, 2004·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Antonio Cesar Tamayo, Paola Andrea Diaz-Zuluaga
Mar 25, 2006·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Yaping JiRichard J Traub
Jun 13, 2006·Drug Delivery·Kyriaki MystakidouMarinos L Tsiatas

❮ Previous
Next ❯

Citations

Mar 19, 2014·Future Medicinal Chemistry·Ruben S Vardanyan, Victor J Hruby
Oct 2, 2009·Peptides·Richard J Bodnar
Aug 1, 2009·Reumatología clinica·Carlos Goicoechea García, María Isabel Martín Fontelles
Dec 7, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Xiu E FengQing Shan Li
Jul 21, 2017·Journal of Medicinal Chemistry·Lokesh RavillaKuppuswamy Nagarajan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.